Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis–Menten constants

By Youdim K.   Dodia R.  

Xenobiotica, Vol. 40, Iss. 4, 2010-04 ,pp. : 235-244

Informa Healthcare

Access to resources Recommend Favorite

Reconstitution of Recombinant Cytochrome P450 2C10(2C9) and Comparison with Cytochrome P450 3A4 and Other Forms: Effects of Cytochrome P450-P450 and Cytochrome P450-b 5 Interactions

By Yamazaki H.   Gillam E.M.J.   Dong M.S.   Johnson W.W.   Guengerich F.P.   Shimada T.  

Archives of Biochemistry and Biophysics, Vol. 342, Iss. 2, 1997-06 ,pp. : 329-337

Elsevier

Access to resources Recommend Favorite

Reconstitution Premixes for Assays Using Purified Recombinant Human Cytochrome P450, NADPH-Cytochrome P450 Reductase, and Cytochrome b5

By Shaw P.M.   Hosea N.A.   Thompson D.V.   Lenius J.M.   Guengerich F.P.  

Archives of Biochemistry and Biophysics, Vol. 348, Iss. 1, 1997-12 ,pp. : 107-115

Elsevier

Access to resources Recommend Favorite

Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP)

By Sams C.   Cocker J.   Lennard M. S.  

Xenobiotica, Vol. 34, Iss. 10, 2004-10 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms

By Subrahmanyam V.   Renwick A. B.   Walters D. G.   Price R. J.   Tonelli A. P.   Lake B. G.  

Xenobiotica, Vol. 32, Iss. 6, 2002-06 ,pp. : 521-534

Informa Healthcare

Access to resources Recommend Favorite